No items found.
No items found.
Left chevron

Go Back

Pharmacology

LABA (Long-Acting Beta Agonists) Bronchodilators for Asthma & COPD

LABA bronchodilators explained for asthma & COPD: pharmacology, inhaler use, key drugs, side effects, and clinical safety tips.

Video thumbnail

To view this video, please enable marketing cookies from Cookie Preferences in the footer.

Horizontal dot pattern

In this lecture from This is Why, Dr. Busti will explain how Long-Acting Beta Agonists (LABAs) work, where they fit in therapy for the management of asthma and COPD.

You’ll learn how to:
- Mechanism of action: beta-2 receptor activation → bronchodilation (airway smooth muscle relaxation)
- Clinical use: LABAs in COPD maintenance vs asthma (must be combined with ICS)
- Onset/duration differences and practical inhaler considerations
- Adverse effects & warnings: tachycardia, tremor, hypokalemia, paradoxical bronchospasm, and key safety concepts
- Therapeutic combos: ICS/LABA combination inhalers and where they fit (including common guideline concepts)

LABA drugs discussed for SEO/review:
- Salmeterol
- Formoterol
- Vilanterol
- Olodaterol
- Indacaterol

The goal = make medical education easy and clinically relevant.


Chapter Table of Contents
00:00 LABAs Overview: Role in Asthma & COPD Symptom Control (12–24 Hours)
03:03 Indications & Uses: Asthma, COPD, Exercise-Induced Bronchospasm
05:07 Asthma vs COPD Basics: Inflammation Type & Response to Bronchodilators/ICS
07:11 ACOS Explained: Asthma–COPD Overlap and Why It Matters for Therapy
09:16 Net Benefit: Better Daily/Nocturnal Symptoms + Lung Function, Fewer Visits
10:45 Why Delivery Matters: Getting Drug to Bronchioles (Not Oropharynx)
15:17 Pathophysiology Visuals: Asthma Bronchospasm vs COPD Mucus/Remodeling
17:40 Mechanism: Beta-2 → ↑cAMP/PKA → ↓Ca²⁺ & ↓Myosin Phosphorylation
21:04 Why “Long-Acting”: Lipid Solubility, Receptor Interaction, Selectivity
23:00 Dosing Patterns: 12-Hour (BID) vs Ultra-Long (QD) + Desensitization Concept
25:04 Inhaler Technique Pearls: MDI vs DPI vs Nebs + Spacer, Breath Hold 10 sec
30:55 Clinical Rules: No LABA Monotherapy in Asthma + Combo/Triple Therapy & Monitoring


If this helped you, please like, subscribe to our YouTube Channel, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

Don’t forget to turn on notifications on YouTube so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#LABA #LongActingBetaAgonist #Asthma #Bronchodilators #busti

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

This is why - membership

More than just access—it’s where understanding deepens.

Create a free account or log in to gain access to this content!

Dot pattern graphic

Dive Deeper

Bonus Video (ad free)

Deep Dive video thumbnail

To view this video, please enable marketing cookies.

Downloads

Bronchodilators LABA & SABA Lecture Tables and Diagrams

Dive Deeper

Bonus Video

Downloads

Bronchodilators LABA & SABA Lecture Tables and Diagrams